| __timestamp | Dynavax Technologies Corporation | Opthea Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 84580000 | 3401685 |
| Thursday, January 1, 2015 | 86943000 | 4284228 |
| Friday, January 1, 2016 | 84493000 | 3581295 |
| Sunday, January 1, 2017 | 64988000 | 4838300 |
| Monday, January 1, 2018 | 74951000 | 24891534 |
| Tuesday, January 1, 2019 | 62331000 | 31347891 |
| Wednesday, January 1, 2020 | 28607000 | 17480747 |
| Friday, January 1, 2021 | 32228000 | 34710152 |
| Saturday, January 1, 2022 | 46600000 | 108459978 |
| Sunday, January 1, 2023 | 54886000 | 181563523 |
| Monday, January 1, 2024 | 176326321 |
Igniting the spark of knowledge
In the ever-evolving landscape of biotechnology, research and development (R&D) budgets are a key indicator of a company's commitment to innovation. Over the past decade, Opthea Limited and Dynavax Technologies Corporation have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Dynavax's R&D expenses peaked in 2015, with a notable 87 million USD, before experiencing a gradual decline. In contrast, Opthea's R&D spending surged dramatically, increasing by over 5000% from 2014 to 2023, reaching a high of approximately 182 million USD. This stark difference highlights Opthea's aggressive push towards innovation, particularly in recent years. The data for 2024 is incomplete, but the trend suggests Opthea's continued focus on R&D. As these companies forge ahead, their R&D strategies will likely play a pivotal role in shaping their future success.
Comparing Innovation Spending: Eli Lilly and Company and Opthea Limited
Vertex Pharmaceuticals Incorporated or Dynavax Technologies Corporation: Who Invests More in Innovation?
Research and Development Investment: Zoetis Inc. vs Opthea Limited
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Opthea Limited
R&D Insights: How Incyte Corporation and Dynavax Technologies Corporation Allocate Funds
Research and Development Investment: Halozyme Therapeutics, Inc. vs Opthea Limited
Blueprint Medicines Corporation vs Opthea Limited: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Opthea Limited and CymaBay Therapeutics, Inc.
Analyzing R&D Budgets: Opthea Limited vs Veracyte, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Opthea Limited and Bausch Health Companies Inc.
Comparing Innovation Spending: Opthea Limited and Viridian Therapeutics, Inc.
R&D Insights: How Amneal Pharmaceuticals, Inc. and Dynavax Technologies Corporation Allocate Funds